Amoxicillin Dosing for Acute Otitis Media in Adults
For acute otitis media in an otherwise healthy adult, prescribe amoxicillin 500 mg twice daily for 10 days.
Dosing Rationale
While the provided evidence focuses heavily on streptococcal pharyngitis and pediatric AOM, the bacteriology of adult AOM and general antibiotic dosing principles support this recommendation:
Adult-Specific Considerations
The bacteriology of adult AOM mirrors that of children, with Haemophilus influenzae (26%) and Streptococcus pneumoniae (21%) being the predominant pathogens 1. This bacterial profile supports amoxicillin as first-line therapy, as it provides appropriate coverage for these organisms.
Standard Adult Dosing
- Amoxicillin 500 mg twice daily (BID) for 10 days is the established adult dose for respiratory tract infections 2
- This dosing appears consistently across multiple guidelines for adult bacterial infections of the respiratory tract
- The 10-day duration is standard for bacterial otitis media treatment
Why This Dose Works
The pharmacokinetics support this regimen: 500 mg doses produce peak blood levels of 5.5-7.5 mcg/mL within 1-2 hours 3, providing adequate tissue penetration for middle ear infections. Amoxicillin diffuses readily into most body tissues and fluids 3.
Alternative Considerations
If Beta-Lactamase Producers Suspected
If the patient has:
- Failed initial amoxicillin therapy
- Recent antibiotic exposure (within 30 days)
- High local resistance rates
Consider amoxicillin-clavulanate 875 mg twice daily instead 2. However, beta-lactamase production in adult AOM is relatively uncommon (9% overall) 1, so this is not routinely necessary for initial therapy.
Penicillin Allergy
For true penicillin allergy:
- Cefuroxime 250-500 mg twice daily (avoid in immediate hypersensitivity)
- Azithromycin 500 mg once daily for 5 days
- Clarithromycin 500 mg twice daily for 10 days
These alternatives are extrapolated from respiratory infection guidelines 2.
Important Caveats
Do not use penicillin V, cephalexin, erythromycin, or tetracyclines as first-line therapy—these lack adequate activity against H. influenzae, a major pathogen in adult AOM 1.
The evidence base for adult AOM treatment is limited compared to pediatric data, but the bacterial etiology and clinical experience support amoxicillin as appropriate first-line empiric therapy 1.